IPCA Laboratories Limited

IPCA Laboratories Limited

1,950.00
INR
+47.25
(+2.48%)
54.21EPS
32.97P/E
431.87BMarket Cap
Nov 09Next Earn

Latest Stock Split

Jan 10, 2022

2:1

For every share held, investors received 2. The price per share adjusted from $2198.55 to $1099.28.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jan 10, 2022
    Before$2198.55
    Split ratio2:1
    After$1099.28
    Forward
  2. Mar 22, 2010
    Before$1281.90
    Split ratio5:1
    After$256.38
    Forward
  3. Jan 28, 2005
    Before$847.25
    Split ratio2:1
    After$423.63
    Forward

About IPCA Laboratories Limited stock splits

IPCA Laboratories Limited (BSE:IPCALAB) operates in the Pharmaceuticals: major industry.

IPCA Laboratories Limited company overview

When did IPCA Laboratories Limited stock split?

IPCA Laboratories Limited's most recent stock split was on January 10, 2022. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.

What is IPCA Laboratories Limited's stock split history?

IPCA Laboratories Limited (BSE:IPCALAB) has split its stock 3 times: a 2-for-1 split on January 28, 2005, a 5-for-1 split on March 22, 2010, and a 2-for-1 split on January 10, 2022.

How many times has IPCA Laboratories Limited stock split?

IPCA Laboratories Limited has split its stock 3 times. This history records 3 forward splits between January 28, 2005 and January 10, 2022.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In IPCA Laboratories Limited's 2-for-1 split on January 10, 2022, every share became 2 shares.

Will IPCA Laboratories Limited split its stock again?

IPCA Laboratories Limited has not announced a new split in our records. Its most recent split was on January 10, 2022, 4 years ago. Companies announce splits in advance, and any new BSE:IPCALAB split will appear on this page.